Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiziano Barbui

Showing results (1-10 of 315) with videos related to

Pageof 32
Sort By:
American Journal of Hematology|February 4, 2016
Refining prognostication of thrombosis in ETTiziano Barbui
Seminars in Hematology|April 12, 2003
Indications for lowering platelet numbers in essential thrombocythemiaTiziano Barbui
Current Opinion in Oncology|October 12, 2011
How to manage thrombosis in myeloproliferative neoplasmsTiziano Barbui
European Journal of Haematology. Supplementum|August 31, 2007
Evolving management of essential thrombocythaemiaTiziano Barbui
International Journal of Hematology|November 15, 2002
What is the standard treatment in essential thrombocythemiaTiziano Barbui
Seminars in Hematology|June 11, 2004
The leukemia controversy in myeloproliferative disorders: is it a natural progression of disease, a secondary sequela of therapy, or a combination of both?Tiziano Barbui
American Journal of Hematology|May 17, 2024
Paving the path for ongoing clinical research and education in post retirement ageTiziano Barbui
Mayo Clinic Proceedings|September 11, 2015
Essential Thrombocythemia and Polycythemia Vera: Focus on Clinical PracticeAyalew Tefferi, Tiziano Barbui
Best Practice & Research. Clinical Haematology|June 20, 2006
Evidence-based management of polycythemia veraTiziano Barbui, Guido Finazzi
Blood Reviews|June 21, 2005
Risk-adapted therapy in essential thrombocythemia and polycythemia veraGuido Finazzi, Tiziano Barbui
Pageof 32

Showing results (1-10 of 315) with videos related to

Sort By:
Pageof 32
American Journal of Hematology|February 4, 2016
Refining prognostication of thrombosis in ETTiziano Barbui
Seminars in Hematology|April 12, 2003
Indications for lowering platelet numbers in essential thrombocythemiaTiziano Barbui
Current Opinion in Oncology|October 12, 2011
How to manage thrombosis in myeloproliferative neoplasmsTiziano Barbui
European Journal of Haematology. Supplementum|August 31, 2007
Evolving management of essential thrombocythaemiaTiziano Barbui
International Journal of Hematology|November 15, 2002
What is the standard treatment in essential thrombocythemiaTiziano Barbui
Seminars in Hematology|June 11, 2004
The leukemia controversy in myeloproliferative disorders: is it a natural progression of disease, a secondary sequela of therapy, or a combination of both?Tiziano Barbui
American Journal of Hematology|May 17, 2024
Paving the path for ongoing clinical research and education in post retirement ageTiziano Barbui
Mayo Clinic Proceedings|September 11, 2015
Essential Thrombocythemia and Polycythemia Vera: Focus on Clinical PracticeAyalew Tefferi, Tiziano Barbui
Best Practice & Research. Clinical Haematology|June 20, 2006
Evidence-based management of polycythemia veraTiziano Barbui, Guido Finazzi
Blood Reviews|June 21, 2005
Risk-adapted therapy in essential thrombocythemia and polycythemia veraGuido Finazzi, Tiziano Barbui
Pageof 32